Belnap v. Howard , 437 P.3d 355 ( 2019 )


Menu:
  •                  This opinion is subject to revision before final
    publication in the Pacific Reporter
    
    2019 UT 9
    IN THE
    SUPREME COURT OF THE STATE OF UTAH
    LEGRAND P. BELNAP, M.D.,
    Petitioner,
    v.
    BEN HOWARD, M.D.,
    and STEVEN MINTZ, M.D.,
    Respondents.
    No. 20170628
    Filed February 28, 2019
    On Appeal of Interlocutory Order
    Third District, Salt Lake
    The Honorable Matthew Bates
    No. 160902832
    Attorneys:
    Peter Stirba, Scott G. Higley, Salt Lake City, for petitioners
    Francis M. Wikstrom, Juliette P. White, Alan S. Mouritsen, Salt Lake
    City, for respondents
    CHIEF JUSTICE DURRANT authored the opinion of the Court, in
    which ASSOCIATE CHIEF JUSTICE LEE, JUSTICE HIMONAS, JUSTICE
    PEARCE, and JUDGE KATE APPLEBY joined.
    Having recused herself, JUSTICE PETERSEN did not participate herein.
    COURT OF APPEALS JUDGE KATE APPLEBY sat.
    CHIEF JUSTICE DURRANT, opinion of the Court:
    Introduction
    ¶1 Rule 26(b)(1) of the Utah Rules of Civil Procedure
    establishes discovery and evidentiary privileges for statements made
    and documents prepared as part of a health care provider’s peer
    review process. In this case, the parties dispute whether there is an
    BELNAP v. HOWARD
    Opinion of the Court
    exception to these privileges for information provided in bad faith.
    Dr. LeGrand P. Belnap was denied discovery as to allegedly
    defamatory statements made by Drs. Ben Howard and Steven Mintz
    in peer review meetings. These statements concerned Dr. Belnap’s
    application for surgical privileges at Jordan Valley Medical Center
    (JVMC). After the district court denied Dr. Belnap discovery, he filed
    this interlocutory appeal. Because we find that there is no bad faith
    exception to rule 26(b)(1), we affirm.
    Background
    ¶2 In 2009, Dr. Belnap obtained active staff membership and
    full surgical privileges at Salt Lake Regional Medical Center
    (SLRMC), a facility owned by Iasis Healthcare Corporation (Iasis). In
    2013, SLRMC’s Medical Executive Committee, which included
    Dr. Howard, summarily suspended Dr. Belnap’s privileges. The
    following month, a hearing was held. SLRMC later vacated
    Dr. Belnap’s suspension in full, and he returned to full surgical
    privileges.
    ¶3 In September 2013, Dr. Belnap submitted an application to
    Jordan Valley Medical Center (JVMC)—also owned by Iasis—for
    appointment to the medical staff and for clinical privileges. In the
    course of reviewing Dr. Belnap’s application, Jordan Valley’s
    Medical Executive Committee (the Executive Committee) solicited
    input from physicians with whom Dr. Belnap had previously
    worked, including Drs. Howard and Mintz.
    ¶4 In May 2015, “Dr. Belnap’s counsel received a redacted copy
    of the minutes from a secret [Executive Committee] meeting held on
    January 21, 2015.” In an amended complaint, Dr. Belnap brought
    four claims: defamation, tortious interference with prospective
    economic relations, state antitrust violations, and intentional
    infliction of emotional distress. The amended complaint describes in
    specific detail the statements Drs. Howard and Mintz allegedly
    made on January 21, 2015.
    ¶5 Drs. Howard and Mintz filed two motions seeking to strike
    Dr. Belnap’s amended complaint or to classify it as privileged under
    the peer review privilege. The district court denied both motions.
    Dr. Belnap then filed a notice of deposition of both Drs. Howard and
    Mintz. Drs. Howard and Mintz filed a statement of discovery issues
    asking the district court, under Utah Rule of Civil Procedure 26(b)(1)
    and Utah Code section 26-25-3, to prohibit the discovery, use, or
    admission into evidence of several documents created during the
    peer review process and the testimony provided on January 21. The
    2
    Cite as: 
    2019 UT 9
                                Opinion of the Court
    district court granted the restrictions sought by Drs. Howard and
    Mintz in their statement of discovery issues.
    ¶6 Dr. Belnap timely filed a petition for interlocutory appeal in
    this court. We have jurisdiction pursuant to Utah Rule of Appellate
    Procedure 5 and Utah Code section 78A-3-102(3)(j).
    Issue and Standard of Review
    ¶7 We must determine whether there is an exception to the
    peer review privilege in Utah Rule of Civil Procedure 26(b)(1) for
    statements made in bad faith. “The existence of a privilege is a
    question of law for the court, which we review for correctness,
    giving no deference to the trial court’s determination.” 1 And a
    “district court’s interpretation of a rule of civil procedure presents a
    question of law that is reviewed for correctness.” 2
    Analysis
    ¶8 Dr. Belnap argues that Utah Rule of Civil
    Procedure 26(b)(1)’s privilege language is ambiguous and, when
    read in conjunction with the legislative note accompanying that rule,
    includes a bad faith exception. Because we find that there is no bad
    faith exception in the plain language or the legislative note, we
    affirm.
    I. There Is No Bad Faith Exception to Rule 26(b)(1)’s
    Peer Review Privilege
    ¶9 We are asked to interpret the discovery privilege provided
    by Utah Rule of Civil Procedure 26(b)(1). “[W]hen construing a
    statute, we seek to give effect to the intent of the Legislature.” 3 So we
    “begin with the plain language of the provision at issue in our
    broader effort to ascertain the intent of the Legislature disclosed by
    the language of the act as a whole, the act’s operation, and its
    purpose.” 4 “Only when we find ambiguity in the statute’s plain
    _____________________________________________________________
    1 Moler v. CW Mgmt. Corp., 
    2008 UT 46
    , ¶ 7, 
    190 P.3d 1250
    (quoting Price v. Armour, 
    949 P.2d 1251
    , 1254 (Utah 1997)).
    2 Aequitas Enters., LLC v. Interstate Inv. Grp., LLC, 
    2011 UT 82
    , ¶ 7,
    
    267 P.3d 923
    .
    3   State v. Rasabout, 
    2015 UT 72
    , ¶ 10, 
    356 P.3d 1258
    .
    4   
    Id. 3 BELNAP
    v. HOWARD
    Opinion of the Court
    language need we seek guidance from the legislative history and
    relevant policy considerations.” 5
    ¶10 In this case, nothing in the text of rule 26(b)(1) indicates the
    existence of a bad faith exception. The rule states, in relevant part:
    Privileged matters that are not discoverable or
    admissible in any proceeding of any kind or character
    include all information in any form provided during
    and created specifically as part of a request for an
    investigation,   the    investigation,   findings,   or
    conclusions of peer review, care review, or quality
    assurance processes of any organization of health care
    providers as defined in the Utah Health Care
    Malpractice Act for the purpose of evaluating care
    provided to reduce morbidity and mortality or to
    improve the quality of medical care, or for the purpose
    of peer review of the ethics, competence, or
    professional conduct of any health care provider. 6
    The text of rule 26(b)(1) does not mention a bad faith exception. The
    rule prohibits discovery of privileged matters “in any proceeding of
    any kind” and includes “all information in any form” provided at any
    stage of a peer review, care review, or quality assurance process. 7
    This language is certainly broad enough to prohibit even the
    discovery of statements made in bad faith as part of a peer review
    meeting. 8
    _____________________________________________________________
    5World Peace Movement of Am. v. Newspaper Agency Corp., Inc., 
    879 P.2d 253
    , 259 (Utah 1994).
    6   UTAH R. CIV. P. 26(b)(1).
    7   
    Id. (emphases added).
       8 The discovery privilege set out in rule 26(b)(1) applies to both
    the care review and the peer review process. The care review
    privilege “authorizes, without the risk of liability, certain private
    medical information to be provided to select entities” for two
    purposes: “(a) study[ing] and advancing medical research, with the
    purpose of reducing the incidence of disease, morbidity, or
    mortality; or (b) the evaluation and improvement of hospital and
    health care rendered by hospitals, health facilities, or health care
    providers.” Vered v. Tooele Hosp. Corp., 
    2018 UT App 15
    , ¶ 18, 
    414 P.3d 1004
    (quoting UTAH CODE § 26-25-1(3)); see also Benson v. I.H.C.
    (Continued)
    4
    Cite as: 
    2019 UT 9
                                Opinion of the Court
    ¶11 The language does reference the definitions in the Utah
    Health Care Malpractice Act, but nothing in that act can be read to
    create a bad faith exception to rule 26(b)(1). 9 So under the plain
    meaning of the text of rule 26(b)(1), there is no bad faith exception to
    the discovery privilege at issue here.
    II. The Legislative Note Appended to Rule 26(b)(1) Does Not
    Create a Bad Faith Exception
    ¶12 Even though nothing in the text of rule 26(b)(1) indicates the
    existence of a bad faith exception, Dr. Belnap argues that the term
    “privilege” becomes ambiguous when the legislative note is read as
    part of the rule, and that the best reading of the note is that it creates
    a bad faith exception to the privilege rule. Because we conclude that
    the plain meaning of the text of rule 26(b)(1) is unambiguous, it is
    questionable whether it is proper to consider the note as part of our
    analysis. But because our consideration of the note does not change
    our result, we examine it briefly here.
    A. It is questionable whether we should consider the legislative
    note as part of the text of rule 26(b)(1)
    ¶13 While “it is sometimes appropriate to consider legislative
    history when interpreting statutes, we will not do so when a statute
    is, as here, unambiguous.” 10 In other words, when the language of a
    rule or statute is clear, we do not look to other sources, such as
    legislative history, for interpretive guidance. 11 Instead, only when
    we find ambiguity do we turn to additional tools to help us
    understand the rule. 12
    Hosps., Inc., 
    866 P.2d 537
    , 539 (Utah 1993). On the other hand, the
    peer review privilege “protects reviews undertaken ‘for the purpose
    of evaluating any health care provider regarding (a) professional
    ethics, (b) medical competence, (c) moral turpitude, or (d) substance
    abuse.’” Vered, 
    2018 UT App 15
    , ¶ 19 (citation omitted). Because the
    alleged defamatory statements here occurred during a peer review
    process, much of our opinion focuses on the peer review process.
    9   See UTAH CODE §§ 78B-3-401 to -426.
    10 Allred v. Saunders, 
    2014 UT 43
    , ¶ 18, 
    342 P.3d 204
    (interpreting
    rule 26 and referencing the accompanying legislative note).
    11   State v. Barrett, 
    2005 UT 88
    , ¶ 29, 
    127 P.3d 682
    .
    12   
    Id. 5 BELNAP
    v. HOWARD
    Opinion of the Court
    ¶14 In this case, the legislative note to which Dr. Belnap refers
    was enacted together with the rest of the rule amendment. 13 So,
    unlike most legislative history, the note is not merely an interpretive
    statement added after the passing of the bill. Because the legislature
    enacted the note along with the rule, we could view it as part of the
    statute, similar to a preamble. And we have held that although
    preambles are “not a substantive part of the statute,” they may
    provide guidance “as to how the act should be enforced and
    interpreted” and “may be used to clarify ambiguities.” 14
    ¶15 We have, however, previously interpreted the note at issue
    in this case to be nothing more than legislative history.15 In our 2014
    Allred v. Saunders case, we referenced the note accompanying rule 26
    and stated that “in no event will we look to unenacted legislative
    statements that contradict the plain text of the enactment.” 16 So
    alternatively, we could treat the note more like an advisory
    committee note. But we generally do not look to advisory committee
    notes or other sources of interpretive guidance “when the language
    of the statute is plain.” 17 Because the language of rule 26(b)(1) is
    plain, if we consider the note to be the equivalent of an advisory
    committee note, it would be improper to consider it.
    ¶16 But we need not determine whether we should treat the
    note at issue in this case as something akin to a preamble or an
    advisory committee note, because we reach the same result
    regardless of how we treat it.
    _____________________________________________________________
    13   S.J.R. 15, 59th Leg., Gen. Sess. (Utah 2012).
    14   Price Dev. Co., L.P. v. Orem City, 
    2000 UT 26
    , ¶ 23, 
    995 P.2d 1237
    .
    15 Allred, 
    2014 UT 43
    , ¶ 18. Our statement in this case about the
    nature of the note may be more a factual observation than a
    statement of law, so the precedential effect is unclear. But we need
    not reach this question, because even if we assign the note the same
    weight as the statutory language, the result is the same. See infra
    section II.B.
    16   
    Id. 17 Barrett,
    2005 UT 88
    , ¶ 29.
    6
    Cite as: 
    2019 UT 9
                                Opinion of the Court
    B. Even were we to assign the legislative note the same weight
    as the statutory language, we would still
    find no bad faith exception
    ¶17 The legislative note at issue in this case states that
    rule 26(b)(1) “intended to incorporate long-standing protections
    against discovery and admission into evidence of privileged matters
    connected to medical care review and peer review into the Utah
    Rules of Civil Procedure.” 18 It then states that these “privileges” are
    found in “both Utah common law and statute” and “include
    Sections 26-25-3, 58-13-4, and 58-13-5” of the Utah Code. 19 Dr. Belnap
    _____________________________________________________________
    18 UTAH R. CIV. P. 26, legislative note 1 to 2012 amendment. The
    note in its entirety reads:
    The amended language in paragraph (b)(1) is intended
    to incorporate long-standing protections against
    discovery and admission into evidence of privileged
    matters connected to medical care review and peer
    review into the Utah Rules of Civil Procedure. These
    privileges, found in both Utah common law and
    statute, include Sections 26-25-3, 58-13-4, and 58-13-5,
    UCA, 1953. The language is intended to ensure the
    confidentiality of peer review, care review, and quality
    assurance processes and to ensure that the privilege is
    limited only to documents and information created
    specifically as part of the processes. It does not extend
    to knowledge gained or documents created outside or
    independent of the processes. The language is not
    intended to limit the court’s existing ability, if it
    chooses, to review contested documents in camera in
    order to determine whether the documents fall within
    the privilege. The language is not intended to alter any
    existing law, rule, or regulation relating to the
    confidentiality, admissibility, or disclosure of
    proceedings before the Utah Division of Occupational
    and Professional Licensing. The Legislature intends
    that these privileges apply to all pending and future
    proceedings governed by court rules, including
    administrative proceedings regarding licensing and
    reimbursement.
    19   
    Id. 7 BELNAP
    v. HOWARD
    Opinion of the Court
    argues that the incorporation of these statutory provisions creates a
    bad faith exception. We disagree.
    ¶18 Section 26-25-3, in conjunction with section 26-25-1,
    provides both a discovery and an evidentiary privilege for
    information and statements made as part of care and peer review
    processes. As we later discuss, this section was held inoperative by
    one of our district courts, and was later incorporated into
    rule 26(b)(1). 20 Significantly, this rule does not include a bad faith
    exception.
    ¶19 In contrast to the discovery and evidentiary privileges in
    section 26-25-3, sections 58-13-4 and 58-13-5 create an immunity from
    liability in certain circumstances. Section 58-13-4 provides that
    individuals participating in a care review process are immune from
    liability arising from that process, as long as they participate in good
    faith. Section 58-13-5 similarly states that individuals participating in
    a peer review process are immune from liability arising from that
    process, as long as they participate in good faith.
    ¶20 Dr. Belnap argues that reading section 26-25-3 together with
    sections 58-13-4 and 58-13-5 suggests that a bad faith exception
    should be incorporated into section 26-25-3, and by extension,
    rule 26(b)(1). But our review of the history behind the statutes
    referenced in the note leads us to conclude that none of the statutory
    provisions Dr. Belnap cites injects a bad faith exception into
    rule 26(b)(1).
    ¶21 The legislature enacted the first iteration of Utah Code
    section 58-13-4 in 1969. 21 This section provided then and provides
    now immunity for health care professionals participating in the care
    review process, as long as they do so in good faith. 22 In 1996, the
    legislature added a provision similar to section 58-13-4, section 58-
    13-5, which provides for the same qualified immunity in the peer
    review process. 23
    _____________________________________________________________
    20Jones v. Univ. of Utah Health Sci. Ctr., No. 100419242, 
    2012 WL 602613
    (Utah Dist. Ct. Jan. 13, 2012).
    21  1969 Utah Laws 669. When first enacted, section 58-13-4 was
    listed as section 58-12-25.
    22   UTAH CODE § 58-13-4.
    23 1996 Utah Laws 1292. When first enacted, section 58-13-5 was
    listed as section 58-12-25.5.
    8
    Cite as: 
    2019 UT 9
                                Opinion of the Court
    ¶22 In 1981, the legislature enacted what are now Utah Code
    sections 26-25-1 and 26-25-3. 24 The legislature amended
    section 26-25-3 in 1994 to include a protection against discovery.25
    Prior to that, the section had provided only an evidentiary
    protection. 26 These sections now operate together to “protect
    information compiled or created during the peer-review . . . process
    from both discovery and receipt into evidence.” 27
    ¶23 In 2012, one of our district courts “held that the
    Legislature’s 1994 amendment to section 26-25-3 was inoperative”
    because it had failed to go through the proper process for amending
    a rule of evidence. 28 After this ruling, the Utah legislature properly
    amended Rule 26 of the Utah Rules of Civil Procedure to codify
    these peer and care review privileges. 29 As part of the 2012
    amendment, the legislature included a legislative note with the
    enacted bill. 30
    ¶24 Importantly, nothing in the legislative note mentions a bad
    faith exception. But the note does reference Utah Code
    sections 26-25-3, 58-13-4, and 58-13-5 as the sources of the peer and
    care review privileges. 31 Rule 26(b)(1) and Utah Code section 26-25-3
    both deal with the protections against discovery. And neither
    provision mentions a bad faith exception.
    ¶25 But Utah Code sections 58-13-4 and 58-13-5,        on the other
    hand, both provide that individuals participating in      the care and
    peer review processes have qualified immunity from        liability. Such
    individuals are shielded from liability only when they    participate in
    these processes in good faith. 32
    _____________________________________________________________
    24   1981 Utah Laws 731–32.
    25   See Jones, 
    2012 WL 602613
    .
    26   
    Id. 27 Allred,
    2014 UT 43
    , ¶ 9.
    28   
    Id. ¶ 11
    (citing Jones, 
    2012 WL 602613
    ).
    29   
    Id. ¶ 12.
       30   S.J.R. 15, 59th Leg., Gen. Sess. (Utah 2012).
    31   UTAH R. CIV. P. 26 legislative note 1 to 2012 amendment.
    32   UTAH CODE §§ 58-13-4, -5.
    9
    BELNAP v. HOWARD
    Opinion of the Court
    ¶26 In other words, the immunity from liability set forth in
    sections 58-13-4 and 58-13-5 is subject to a bad faith exception while
    the discovery privilege in rule 26(b)(1) and section 26-25-3 is not.
    And it is the discovery privilege that is at issue in the case before us.
    ¶27 Dr. Belnap notes, however, that Utah Code section 58-13-4’s
    initial enactment predated the initial enactment of sections 26-25-1
    and 26-25-3, and there was a good faith requirement in
    section 58-13-4 from that initial enactment. Based on this chronology,
    he argues that sections 26-25-1 and 26-25-3 incorporate the good faith
    requirement from previously enacted section 58-13-4. We do
    presume that “whenever the legislature enacts a provision it has in
    mind previous statutes relating to the same subject matter.” 33 But we
    also seek “to give effect to omissions in statutory language by
    presuming all omissions to be purposeful.” 34 Based on this canon,
    and given that section 58-13-4 did predate the other sections and did
    include good faith language, we may presume that the legislature
    intentionally omitted that language in sections 26-25-1 and 26-25-3,
    and rule 26. And the fact that section 58-13-4 also predated
    section 58-13-5, but the legislature did include the good faith
    requirement when it later enacted section 58-13-5, supports this
    interpretation. So it is clear that the legislature did not intend to
    simply rely on section 58-13-4 to provide a good faith requirement
    for all subsequent enactments.
    ¶28 The legislative note makes clear that the legislature’s
    intention in amending rule 26 was to maintain the status quo in
    codifying the peer and care review privileges as they existed prior to
    the district court decision overruling the 1994 amendment to Utah
    Code section 26-25-3. 35 Throughout the entire history of these
    statutory provisions, there has never been a bad faith exception to
    the discovery or evidentiary provisions. Further, the only sections
    that have ever included good faith language are those relating to
    immunity—sections 58-13-4 and 58-13-5. And the note itself does not
    have a bad faith exception. The amendment was “intended to
    incorporate long-standing protections against discovery and
    _____________________________________________________________
    33   Murray City v. Hall, 
    663 P.2d 1314
    , 1318 (Utah 1983).
    34 Marion Energy, Inc. v. KFJ Ranch P’ship, 
    2011 UT 50
    , ¶ 14, 
    267 P.3d 863
    .
    35  See UTAH R. CIV. P. 26 legislative note 1 to 2012 amendment; see
    also Jones, 
    2012 WL 602613
    .
    10
    Cite as: 
    2019 UT 9
                              Opinion of the Court
    admission into evidence of privileged matters,” making clear that it
    was not meant to alter existing rules regarding discovery.36 So even
    if we read the legislative note along with the text of the rule, we find
    no bad faith exception to the discovery provision.
    ¶29 We hold that, although there is a bad faith exception to
    immunity from liability, there is no such exception to the discovery
    privilege. Admittedly, as Dr. Belnap argues, there is significant
    tension resulting from the interplay of these two conclusions.
    Together, they allow for the potential imposition of liability, but
    significantly foreclose the pursuit of discovery to prove that liability.
    Other courts in jurisdictions with a similar statutory framework have
    noted this tension and offered reasons why their respective
    legislatures may have treated immunity differently than document
    production. 37 But whatever reasons our legislature may have had for
    _____________________________________________________________
    36   UTAH R. CIV. P. 26 legislative note 1 to 2012 amendment.
    37 See, e.g., Marshall v. Planz, 
    145 F. Supp. 2d 1258
    , 1271 (M.D. Ala.
    2001) (declining to apply a good faith limitation to the peer review
    privilege so the “privilege from testifying was not qualified, but
    immunity from suit was” qualified); Franco v. Dist. Ct. of Denver, 
    641 P.2d 922
    , 930 (Colo. 1982) (“We believe the legislature deliberately
    omitted any good faith limitation in the peer review privilege in
    order to avoid any chilling effect on the review committee’s statutory
    duty . . . .”); Patton v. St. Francis Hosp., 
    539 S.E.2d 526
    , 529 (Ga. Ct.
    App. 2000) (“Since neither the peer review nor medical review
    statutes pertaining to the discovery privilege mention malice, it is
    doubtful that the legislature intended to expand the malice exception
    to the Code sections affording a discovery privilege to peer review
    proceedings.”); Terre Haute Reg’l Hosp., Inc. v. Basden, 
    524 N.E.2d 1306
    , 1310 (Ind. Ct. App. 1988) (“Therefore, the information that [the
    hospital] refused to disclose based upon the confidentiality and
    privilege protection afforded in the Peer Review Statute was not
    subject to disclosure due to lack of good faith on the part of the peer
    review committee or the participants to the investigation.”); Roy v.
    City of Harriman, 
    279 S.W.3d 296
    , 301 (Tenn. Ct. App. 2008) (rejecting
    an argument that conditional immunity created an implied exception
    to the discovery privilege); Irving Healthcare Sys. v. Brooks, 
    927 S.W.2d 12
    , 17 (Tex. 1996) (“[T]he statute reflects the Legislature’s conscious
    decision to allow an affected physician to bring claims against those
    who participate in the peer review process maliciously and without
    (Continued)
    11
    BELNAP v. HOWARD
    Opinion of the Court
    its peer review regime, it is clear that the tension we have described
    predates the amendment to rule 26. This is significant because it
    shows that the legislature has had ample opportunity to resolve it.
    Indeed, throughout the history of amendments to the various peer
    and care review statutes, this distinction has always existed. The
    amendments to the rule merely carried forward this existing tension.
    Conclusion
    ¶30 The plain language of rule 26(b)(1) includes no bad faith
    exception to the application of the peer review discovery privilege.
    And even looking to the legislative history, we still find no bad faith
    exception. Accordingly, we affirm.
    good faith, but nevertheless to maintain the confidentiality of the
    peer review process.”).
    12